Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A1
Volume 16 Supplement 1
Abstracts from the 7th International Conference on cGMP Generators, Effectors and Therapeutic Implications
Meeting abstracts
Edited by Johannes-Peter Stasch, John Burnett, Harald Schmidt, Michaela Kuhn and Franz Hofmann
Publication of this supplement has been fully funded by FEBGLA e.V. Johannes-Peter Stasch is an employee of Bayer Pharma AG, Wuppertal, Germany. He holds many patents on sGC stimulators and sGC activators. John C Burnett Jr is the chairman of the advisory board for Nile Therapeutics and is a Co-Founder and the Chief Scientific Officer for Zumbro Discovery. Mayo Clinic has licensed CD-NP to Nile Therapeutics and MANP to Zumbro Discovery. The other Supplement Editors declare that they have no competing interests.
7th International Conference on cGMP Generators, Effectors and Therapeutic Implications. Go to conference site.
Trier, Germany19-21 June 2015
Page 1 of 3
-
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A2
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A3
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A4
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A5
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A6
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A7
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A8
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A9
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A10
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A11
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A12
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A13
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A14
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A15
-
cGMP and cAMP pathways rearrange ARHGAP17 and ARHGEF6 protein complexes to control Rac1 in platelets
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A16
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A17
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A18
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A19
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A20
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A21
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A22
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A23
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A24
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A25
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A26
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A27
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A28
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A29
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A30
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A31
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A32
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A33
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A34
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A35
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A36
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A37
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A38
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A39
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A40
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A41
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A42
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A43
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A44
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A45
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A46
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A47
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A48
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A49
-
Citation: BMC Pharmacology and Toxicology 2015 16(Suppl 1):A50
Follow
Annual Journal Metrics
-
Speed
77 days to first decision for reviewed manuscripts only
49 days to first decision for all manuscripts
192 days from submission to acceptance
17 days from acceptance to publicationCitation Impact
1.771 - 2-year Impact Factor
2.246 - 5-year Impact Factor
0.886 - Source Normalized Impact per Paper (SNIP)
0.612 - SCImago Journal Rank (SJR)Usage
412,116 Downloads
97 Altmetric Mentions